The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia

Clinical Therapeutics

Volumn 22, Issue 9, 2000, Pages 1085-1096

  David, Stacy R ^a   Taylor, Cindy C ^a   Kinon, Bruce J ^a   Breier, Alan ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Atypical antipsychotic agents; Haloperidol; Olanzapine; Prolactin; Risperidone

Indexed keywords

HALOPERIDOL; OLANZAPINE; PROLACTIN; RISPERIDONE;

AGE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; DRUG WITHDRAWAL; FEMALE; HUMAN; MALE; MULTICENTER STUDY; PROLACTIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SEX DIFFERENCE; TIME; TREATMENT OUTCOME;

EID: 0033815409     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(00)80086-7     Document Type: Article

References (29)

1. Hyperprolactinaemia in antipsychotic-treated patients: Guidelines for avoidance and management
2. Side effect profiles of new antipsychotic agents
3. In vitro and in vivo biochemistry of olanzapine: A novel, atypical antipsychotic drug
4. Clozapine does not elevate serum prolactin levels in healthy men
5. Clozapine: Plasma levels and prolactin response
6. Effects of clozapine on human serum prolactin levels
7. Clozapine and risperidone in chronic schizophrenia: Effects on symptoms, parkinsonian side effects, and neuroendocrine response
8. The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations
9. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: Results of an international collaborative trial
10. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders
11. Olanzapine versus placebo and haloperidol: Acute phase results of the North American Double-Blind Olanzapine Trial
12. Olanzapine versus haloperidol: Acute phase results of the International Double-Blind Olanzapine Trial
13. Multiple fixed doses of 'Seroquel' (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo
14. Stimulation by risperidone of rat prolactin secretion in vivo and in cultured pituitary cells in vitro
15. Risperidone-induced prolactin elevations in premenopausal women with schizophrenia
16. Pharmacokinetics and drug disposition: Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects
17. Prolactin levels and adverse events in patients treated with risperidone
18. Prolactogenic effects of risperidone in male patients - A preliminary study
19. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol
20. Progress in immunoassays for serum prolactin: Evidence from the UK External Quality Assessment Scheme (EQAS). 1980-1989
21. A study of serum prolactin levels in schizophrenia: Comparison of males and females
22. Treatment of schizophrenia. 1999: The Expert Consensus Guideline Series
23. Olanzapine versus placebo: Results of a double-blind, fixed-dose olanzapine trial
24. Therapeutic effect and safety of increasing doses of risperidone (R 64766) in psychotic patients
25. 2-dopamine receptor occupancy measured with IBZM-SPECT
26. 2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia
27. Risperidone and associated amenorrhea: A report of 5 cases
28. Effects of the menstrual cycle on dependent variables in mood disorder research